Photo : Laura Gochicoa, présidente de la Global Lung Initiative (GLI), et Sundeep Salvi, directeur mondial de la Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), ont visité le stand de Sunvou.

At the American Thoracic Society (ATS) 2025 International Meeting, held in San Francisco, USA from May 16 to 21, 2025, Sunvou Medical showcased the world's first clinical combined breath test device, which garnered widespread attention from participants and professionals attending the event. Leading respiratory experts from North America, Europe, and other regions, after experiencing the technology firsthand and learning about its clinical applications, stated that the product “provides a completely new and complete solution for the clinical diagnosis of airway diseases.”

During the exhibition, the innovative device attracted considerable interest from clinicians, researchers, and industry representatives who were eager to explore its potential role in improving respiratory disease assessment and patient management. Academic leaders from international organizations such as GINA, GOLD, and GLI expressed their willingness to collaborate with Sunvou Medical to jointly develop standards for innovative technologies, promote the harmonization of clinical practices, standardize the clinical use of related tests, and maximize their clinical value in routine respiratory care.

Photo : Gregory Downey, ancien président de l'American Thoracic Society (ATS), a visité le stand de Sunvou.

Les solutions de soins primaires et de surveillance de la santé respiratoire à domicile de Sunvou Medical ont également fait l'objet d'une grande attention, plusieurs institutions médicales internationales ayant déjà entamé des discussions concernant l'introduction de produits. Cette exposition a encore renforcé la position de leader de Sunvou dans le domaine du diagnostic et du traitement des maladies respiratoires au niveau mondial.